◀ Back to RELA
ATL3 — RELA
Text-mined interactions from Literome
Ohsugi et al., Carcinogenesis 2005
(Disease Models, Animal...) :
To examine the
effect of a novel
NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin ( DHMEQ ), on
ATL in vivo, we developed an improved severe combined immunodeficiency (SCID) mouse model for ATL
Watanabe et al., Blood 2005
(Leukemia, T-Cell...) :
We conclude that
NF-kappaB is a potential molecular
target for treatment and prevention of
ATL
Cezar-de-Mello et al., Br J Pharmacol 2008
(Neovascularization, Pathologic) :
Because the transcription factor NF-kappaB has been implicated in VEGF mediated MMP expression and EC proliferation, we postulated that ATL-1 might modulate the NF-kappaB pathway and, indeed,
ATL-1 inhibited
NF-kappaB nuclear translocation